loadpatents
name:-0.041124105453491
name:-0.02049994468689
name:-0.013910055160522
MCCOMAS; Casey Cameron Patent Filings

MCCOMAS; Casey Cameron

Patent Applications and Registrations

Patent applications and USPTO patent grants for MCCOMAS; Casey Cameron.The latest application filed is for "rad51 inhibitors".

Company Profile
11.20.43
  • MCCOMAS; Casey Cameron - Phoenixville PA
  • McComas; Casey Cameron - Pheonixville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Rad51 Inhibitors
App 20220259198 - LAPIERRE; Jean-Marc ;   et al.
2022-08-18
RAD51 inhibitors
Grant 11,291,655 - Castro , et al. April 5, 2
2022-04-05
Rad51 Inhibitors
App 20220056022 - CASTRO; Alfredo C. ;   et al.
2022-02-24
RAD51 inhibitors
Grant 11,247,988 - Lapierre , et al. February 15, 2
2022-02-15
RAD51 inhibitors
Grant 11,084,812 - Castro , et al. August 10, 2
2021-08-10
Methods Of Using Rad51 Inhibitors For Treatment Of Pancreatic Cancer
App 20200397760 - CASTRO; Alfredo C. ;   et al.
2020-12-24
Combinations Of Rad51 And Parp Inhibitors
App 20200306229 - CASTRO; Alfredo C. ;   et al.
2020-10-01
Rad51 Inhibitors
App 20200291014 - LAPIERRE; Jean-Marc ;   et al.
2020-09-17
Rad51 Inhibitors
App 20200216437 - CASTRO; Alfredo C. ;   et al.
2020-07-09
Rad51 Inhibitors
App 20200129484 - CASTRO; Alfredo C. ;   et al.
2020-04-30
RAD51 inhibitors
Grant 10,590,122 - Castro , et al.
2020-03-17
RAD51 inhibitors
Grant 10,336,746 - Castro , et al.
2019-07-02
Rad51 Inhibitors
App 20190194182 - CASTRO; Alfredo C. ;   et al.
2019-06-27
RAD51 Inhibitors
App 20190077799 - Castro; Alfredo C. ;   et al.
2019-03-14
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140213571 - Liverton; Nigel J. ;   et al.
2014-07-31
Heterocyclic-substituted Benzofuran Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140199263 - McComas; Casey Cameron ;   et al.
2014-07-17
Inhibitors Of Hepatitis C Virus Ns5b Polymerase
App 20120328569 - McComas; Casey Cameron ;   et al.
2012-12-27
Sulfonylated Heterocycles Useful for Modulation of the Progesterone Receptor
App 20100234422 - McComas; Casey Cameron ;   et al.
2010-09-16
Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
App 20100204228 - McComas; Casey Cameron ;   et al.
2010-08-12
Sulfonylated heterocycles useful for modulation of the progesterone receptor
Grant 7,750,038 - McComas , et al. July 6, 2
2010-07-06
Aryl sulfonamides useful for modulation of the progesterone receptor
Grant 7,723,332 - McComas , et al. May 25, 2
2010-05-25
Substituted benzothiadiazinedioxide derivatives and methods of their use
Grant 7,718,652 - Goldberg , et al. May 18, 2
2010-05-18
Substituted propylamine derivatives and methods of their use
Grant 7,687,529 - McComas , et al. March 30, 2
2010-03-30
Aryl Sulfamide Derivatives And Methods Of Their Use
App 20100029641 - McComas; Casey Cameron ;   et al.
2010-02-04
Imidazolidin-2-one derivatives useful as PR modulators
Grant 7,652,018 - Commons , et al. January 26, 2
2010-01-26
Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
Grant 7,652,062 - McComas , et al. January 26, 2
2010-01-26
Oxazolidine derivatives as PR modulators
Grant 7,649,007 - Commons , et al. January 19, 2
2010-01-19
Oxazolidone derivatives as PR modulators
Grant 7,618,990 - Commons , et al. November 17, 2
2009-11-17
Tricyclic oxazolidone derivatives useful as PR modulators
Grant 7,618,989 - Commons , et al. November 17, 2
2009-11-17
Benzothiadiazolylphenylalkylamine derivatives and methods of their use
Grant 7,601,744 - McComas , et al. October 13, 2
2009-10-13
Aryl sulfamide derivatives and methods of their use
Grant 7,601,722 - McComas , et al. October 13, 2
2009-10-13
Oxazinan-2-one derivatives useful as PR modulators
Grant 7,538,107 - Commons , et al. May 26, 2
2009-05-26
Phenylaminopropanol Derivatives and Methods of Their Use
App 20090099164 - Kim; Callain Younghee ;   et al.
2009-04-16
Phenylaminopropanol Derivatives and Methods of Their Use
App 20090093469 - Kim; Callain Younghee ;   et al.
2009-04-09
Aryl Sulfonamides Useful For Modulation Of The Progesterone Receptor
App 20080221201 - McComas; Casey Cameron ;   et al.
2008-09-11
Sulfonylated Heterocycles Useful For Modulation Of The Progesterone Receptor
App 20080221160 - McComas; Casey Cameron ;   et al.
2008-09-11
Hydroxy-substituted Aryl Sulfamide Derivatives And Methods Of Their Use
App 20080194654 - McComas; Casey Cameron ;   et al.
2008-08-14
Cyclic Sulfonamide Derivatives And Methods Of Their Use
App 20080171737 - Fensome; Andrew ;   et al.
2008-07-17
Aryl Sulfamide Derivatives And Methods Of Their Use
App 20080167303 - McComas; Casey Cameron ;   et al.
2008-07-10
Substituted Benzothiadiazinedioxide Derivatives And Methods Of Their Use
App 20080161295 - Goldberg; Joel Adam ;   et al.
2008-07-03
Aminoalkyl Substituted Aryl Sulfamide Derivatives And Methods Of Their Use
App 20080161366 - McComas; Casey Cameron ;   et al.
2008-07-03
Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
App 20080114050 - Fensome; Andrew ;   et al.
2008-05-15
Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
App 20080064673 - McComas; Casey Cameron ;   et al.
2008-03-13
Imidazolidin-2-one derivatives useful as PR modulators
App 20080045577 - Commons; Thomas Joseph ;   et al.
2008-02-21
Oxazinan-2-one derivatives useful as PR modulators
App 20080045518 - Commons; Thomas Joseph ;   et al.
2008-02-21
Oxazolidine derivatives as PR modulators
App 20080045579 - Commons; Thomas Joseph ;   et al.
2008-02-21
Tricyclic oxazolidone derivatives useful as PR modulators
App 20080045578 - Commons; Thomas Joseph ;   et al.
2008-02-21
Oxazolidone derivatives as PR modulators
App 20080045556 - Commons; Thomas Joseph ;   et al.
2008-02-21
Pyrrolidine and related derivatives useful as PR modulators
App 20080045560 - Commons; Thomas Joseph ;   et al.
2008-02-21
Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
Grant 7,317,037 - Fensome , et al. January 8, 2
2008-01-08
Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
Grant 7,297,713 - McComas , et al. November 20, 2
2007-11-20
Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
Grant 7,291,643 - McComas , et al. November 6, 2
2007-11-06
Substituted propylamine derivatives and methods of their use
App 20070072928 - McComas; Casey Cameron ;   et al.
2007-03-29
Benzothiadiazolylphenylalkylamine derivatives and methods of their use
App 20070072918 - McComas; Casey Cameron ;   et al.
2007-03-29
Phenylaminopropanol derivatives and methods of their use
App 20070072897 - Mahaney; Paige Erin ;   et al.
2007-03-29
Use of progesterone receptor modulators
App 20070027201 - McComas; Casey Cameron ;   et al.
2007-02-01
Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
App 20070027126 - McComas; Casey Cameron ;   et al.
2007-02-01
Cyanopyrrole-phenyl progesterone receptor modulators and uses thereof
App 20070027125 - McComas; Casey Cameron ;   et al.
2007-02-01
Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
App 20060030717 - Fensome; Andrew ;   et al.
2006-02-09
Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
App 20060030615 - Fensome; Andrew ;   et al.
2006-02-09
Progesterone receptor antagonists, contraceptive regimens, and kits
App 20060009509 - Grubb; Gary Sondermann ;   et al.
2006-01-12
Phenylaminopropanol derivatives and methods of their use
App 20050222148 - Kim, Callain Younghee ;   et al.
2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed